Lasa Supergenerics: Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30 September 2025

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.30 P.M. and concluded at 05.00 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025.2. Limited Review Report from Statutory Auditor for the quarter and half year ended on September 30 2025.